Antiplatelet agents are one of the main interventions for recurrent ischemic stroke prevention. Their time of use, dosage, and combination of therapy have different effects in terms of stroke risk reduction and adverse effects. This review provides an evidence-based update of the latest on antiplatelet therapy for stroke prevention.
Keywords: Antiplatelet; Aspirin; Cilostazol; Clopidogrel; Dypiridamole; Hemorrhage; Stroke.
Copyright © 2013 Elsevier Inc. All rights reserved.